Pharmacology and Toxicology
Showing page 19 of 22 pages of list content
-
Identification of SARS-CoV-2 induced pathways reveal drug repurposing strategies
This article's authors -
Tafenoquine inhibits replication of SARS-Cov-2 at pharmacologically relevant concentrations in vitro
This article's authors -
In vitroscreening of herbal medicinal products for their supportive curing potential in the context of SARS-CoV-2
This article's authors -
Pharmacokinetics of Orally Administered GS-441524 in Dogs
This article's authors -
Ambroxol Hydrochloride Inhibits the Interaction between Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein’s Receptor Binding Domain and Recombinant Human ACE2
This article's authors -
Bromodomain and extraterminal protein inhibitor, apabetalone (RVX-208), reduces ACE2 expression and attenuates SARS-CoV-2 infection in vitro
This article's authors -
Discovery of a AhR flavonoid agonist that counter-regulates ACE2 expression in rodent models of inflammation and attenuates ACE2-SARS-CoV2 interaction in vitro
This article's authors -
Stapled peptides based on Human Angiotensin-Converting Enzyme 2 (ACE2) potently inhibit SARS-CoV-2 infection in vitro
This article's authors -
Blockade of SARS-CoV-2 infection in vitro by highly potent PI3K-α/mTOR/BRD4 inhibitor
This article's authors -
Antidepressant and antipsychotic drugs reduce viral infection by SARS-CoV-2 and fluoxetine show antiviral activity against the novel variants in vitro
This article's authors